Clinical Trials Logo

Clinical Trial Summary

The purpose of the Strongest Families (formerly Family Help Program)is to evaluate the effectiveness of the Strongest Families distance intervention compared to usual or standard care that is typically provided to children with mild to moderate Enuresis diagnoses. This is a single-centre trial based at the IWK Health Centre. The primary outcome is change in diagnosis.


Clinical Trial Description

The purpose of the Family Help Program is to deliver, primary care mental health services to children and their families in the comfort and privacy of their own home. Approximately 46 children (5-12 years of age)suffering from pediatric enuresis (at least 2 times a week) will be randomized.

The intervention is delivered from a distance, using the urine alarm system accompanied by educational materials (manuals, video-tapes, audio-tapes) and telephone consultation with a trained paraprofessional "coach" who is supervised by a licensed health care professional. The telephone coach delivers consistent care based on written protocols, with on-going evaluation by a professional team.

Fifty percent of the eligible participants will receive Family Help Program telephone-based treatment and 50% will be referred back to their family physician to receive standard care as determined by that physician. Those receiving standard care will be evaluated for outcome results and then compared to the Family Help treated participants. It is anticipated that Family Help treatment will be proven to be as or more effective than standard care. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00270621
Study type Interventional
Source IWK Health Centre
Contact
Status Completed
Phase Phase 2
Start date June 2003
Completion date April 2008

See also
  Status Clinical Trial Phase
Completed NCT02600676 - Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis N/A
Completed NCT02369445 - Investigation of Teacher-Mediated Toilet Training Using a Manualized Moisture Alarm Intervention N/A
Completed NCT01978210 - Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism N/A
Recruiting NCT06070675 - Comparison of a Paper and Automated Bladder Diary in Pediatric Patients N/A
Completed NCT01747343 - Toilet Training Toddlers and Preschoolers N/A
Recruiting NCT00437528 - Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity Phase 1
Recruiting NCT02699528 - The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder N/A
Withdrawn NCT01861145 - Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea Phase 4
Completed NCT04260646 - Alarm Treatment for Combined Enuresis and Daytime Urinary Incontinence in Children N/A
Completed NCT01367080 - A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg Phase 1
Completed NCT00226122 - The Effect of Indomethacin in Monosymptomatic Enuresis Nocturnal Phase 4
Completed NCT05190601 - Uroflowmetry in Children With Enuresis Nocturnal
Withdrawn NCT03478813 - Voiding School as a Treatment of Children's Day-time Incontinence or Enuresis N/A
Recruiting NCT03399877 - A Study on Accuracy Improvement of Repeated Measure Uroflowmetry- Electromyography N/A
Completed NCT01036841 - Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation Phase 4
Active, not recruiting NCT06185361 - Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis. N/A
Completed NCT04280887 - MyPad - Intelligent Bladder Pre-void Alerting System N/A
Completed NCT00240812 - A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime Bedwetting Phase 2